GB0317988D0 - Splicing variants - Google Patents

Splicing variants

Info

Publication number
GB0317988D0
GB0317988D0 GBGB0317988.4A GB0317988A GB0317988D0 GB 0317988 D0 GB0317988 D0 GB 0317988D0 GB 0317988 A GB0317988 A GB 0317988A GB 0317988 D0 GB0317988 D0 GB 0317988D0
Authority
GB
United Kingdom
Prior art keywords
splicing variants
splicing
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0317988.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0317988.4A priority Critical patent/GB0317988D0/en
Publication of GB0317988D0 publication Critical patent/GB0317988D0/en
Priority to PCT/GB2004/003326 priority patent/WO2005012357A1/en
Priority to EP04743640A priority patent/EP1648938A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0317988.4A 2003-07-31 2003-07-31 Splicing variants Ceased GB0317988D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0317988.4A GB0317988D0 (en) 2003-07-31 2003-07-31 Splicing variants
PCT/GB2004/003326 WO2005012357A1 (en) 2003-07-31 2004-07-30 Bcl-2 splicing variants
EP04743640A EP1648938A1 (en) 2003-07-31 2004-07-30 Bcl-2 splicing variants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317988.4A GB0317988D0 (en) 2003-07-31 2003-07-31 Splicing variants

Publications (1)

Publication Number Publication Date
GB0317988D0 true GB0317988D0 (en) 2003-09-03

Family

ID=27799587

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0317988.4A Ceased GB0317988D0 (en) 2003-07-31 2003-07-31 Splicing variants

Country Status (3)

Country Link
EP (1) EP1648938A1 (en)
GB (1) GB0317988D0 (en)
WO (1) WO2005012357A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956568A1 (en) 1999-01-30 2000-08-17 Roland Kreutzer Method and medicament for inhibiting the expression of a given gene
US7767802B2 (en) * 2001-01-09 2010-08-03 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of anti-apoptotic genes
US7423142B2 (en) 2001-01-09 2008-09-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of anti-apoptotic genes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831066A (en) * 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression

Also Published As

Publication number Publication date
WO2005012357A1 (en) 2005-02-10
EP1648938A1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
HK1097917A1 (en) Substrate-guided optical devices
EP1635197A4 (en) Optical element
AU156191S (en) Eyeglasses
DE502004003476D1 (en) Standfuss
GB2420608B (en) Cladding
AU302665S (en) Eyeglasses
DE502004004146D1 (en) Pyrazolverbindungen
EP1588121A4 (en) Optical assembly
DE112004002769D2 (en) Schienengeführtes transportsystem
EP1635194A4 (en) Optical element
AU152617S (en) Section
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0303474D0 (en) Light
GB0317988D0 (en) Splicing variants
GB0306055D0 (en) Waveguide
AU157611S (en) Eyeglasses
GB2404451B (en) Optical package
AU156190S (en) Eyeglasses
GB0229850D0 (en) Splice variant
GB0229856D0 (en) Splice variant
GB0228776D0 (en) Splice variant
GB0213491D0 (en) Splice variants
AU2834P (en) Baltinblus Gaura lindheimeri
AU2833P (en) Baltinrose Gaura lindheimeri
GB0310016D0 (en) Optical devices

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)